Buccal Drug Delivery Systems Market Is Expected To See Growth Rate Of 9.2% To 2028Posted by rahul nikade on September 19th, 2022 Buccal Drug Delivery Systems Industry Overview The global buccal drug delivery systems market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant growth potential due to constant research and development in this field. Compared to oral dosage form, buccal delivery is considered the most convenient and preferred choice, especially among geriatric patients. This drug delivery route ensures elimination of first pass metabolism, allowing drugs that are pH sensitive and easily degraded to be administered effectively. Quicker absorption, minimized biofluid interaction, reduced side effects, high concentration availability at the target site, and shorter treatment regime are some of the factors responsible for the increased adoption of buccal drug delivery, thus driving the preference for these formulations. Gather more insights about the market drivers, restrains and growth of the Global Buccal Drug Delivery Systems Market Market leaders like Generex, NovaDel, Biodelivery Sciences International, and Transcept Pharmaceuticals are identifying newer drug candidates for formulating into rapid and controlled release buccal tablets, mucoadhesive discs, and lozenges. The most researched area is the development of buccal patches containing insulin to treat diabetes and formulations that control episodes in patients with Parkinson’s. Despite the large investment and study to develop a newer formulation, the year 2020 saw a dramatic decline in this market. Halt on supply logistics, reduced raw material availability, decreased laboratory staff to conduct new research, the economic burden on end-users, and most importantly reduced need of buccal delivery medications led to the dip in the market. However, the market is expected to bounce back by mid-2022. Browse through Grand View Research's Medical Devices Industry Research Reports.
Buccal Drug Delivery Systems Market Segmentation Grand View Research has segmented the global buccal drug delivery systems market on the basis of type, application, end-user, and region: Buccal Drug Delivery Systems Type Outlook (Revenue, USD Million, 2016 - 2028)
Buccal Drug Delivery Systems Application Outlook (Revenue, USD Million, 2016 - 2028)
Buccal Drug Delivery Systems End-user Outlook (Revenue, USD Million, 2016 - 2028)
Buccal Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)
Key Companies profiled: Some prominent players in the global buccal drug delivery systems market include
Order a free sample PDF of the Buccal Drug Delivery Systems Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Like it? Share it! More by this author |